Károly Lozsi

Title: Károly Lozsi: Innovator in Pharmaceutical Development

Introduction

Károly Lozsi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of co-crystals for drug formulation. With a total of 2 patents, his work focuses on innovative solutions for treating neurodegenerative and neurodevelopmental diseases.

Latest Patents

Lozsi's latest patents include the development of Blarcamesine co-crystals for the manufacture of pharmaceutical dosage forms. These patents detail the ZnCl co-crystal of racemic-(±)-blarcamesine hydrochloride, as well as the ZnCl co-crystals of both (S)-(−)-blarcamesine hydrochloride and (R)-(+)-blarcamesine hydrochloride. The processes for preparation and pharmaceutical applications of these co-crystals are aimed at treating conditions such as Alzheimer's disease, Parkinson's disease dementia, and Rett syndrome.

Career Highlights

Károly Lozsi is currently employed at Egis Gyógyszergyár Zrt., a prominent pharmaceutical company in Hungary. His role involves extensive research and development, contributing to the advancement of pharmaceutical technologies. His innovative approaches have positioned him as a key figure in the industry.

Collaborations

Lozsi collaborates with talented professionals in his field, including Zsuzsanna Szokol and Tamás Nagy. Their combined expertise enhances the research and development efforts at Egis Gyógyszergyár Zrt.

Conclusion

Károly Lozsi's contributions to pharmaceutical innovation are noteworthy, particularly in the area of co-crystal development for treating serious neurological conditions. His work continues to impact the field positively, paving the way for future advancements in drug formulation.